↓ Skip to main content

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1

Overview of attention for article published in Frontiers in immunology, February 2018
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
135 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
Published in
Frontiers in immunology, February 2018
DOI 10.3389/fimmu.2018.00345
Pubmed ID
Authors

Yong Gao, Chanuka Wijewardhana, Jamie F. S. Mann

Abstract

It is acknowledged that vaccines remain the best hope for eliminating the HIV-1 epidemic. However, the failure to produce effective vaccine immunogens and the inability of conventional delivery strategies to elicit the desired immune responses remains a central theme and has ultimately led to a significant roadblock in HIV vaccine development. Consequently, significant efforts have been applied to generate novel vaccine antigens and delivery agents, which mimic viral structures for optimal immune induction. Here, we review the latest developments that have occurred in the nanoparticle vaccine field, with special emphasis on strategies that are being utilized to attain highly immunogenic, systemic, and mucosal anti-HIV humoral and cellular immune responses. This includes the design of novel immunogens, the central role of antigen-presenting cells, delivery routes, and biodistribution of nanoparticles to lymph nodes. In particular, we will focus on virus-like-particle formulations and their preclinical uses within the HIV prophylactic vaccine setting.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 135 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 17%
Student > Master 21 16%
Student > Bachelor 18 13%
Researcher 16 12%
Professor > Associate Professor 6 4%
Other 16 12%
Unknown 35 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 28 21%
Immunology and Microbiology 16 12%
Agricultural and Biological Sciences 13 10%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Engineering 7 5%
Other 23 17%
Unknown 38 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2021.
All research outputs
#17,292,294
of 25,382,440 outputs
Outputs from Frontiers in immunology
#20,310
of 31,537 outputs
Outputs of similar age
#222,486
of 344,055 outputs
Outputs of similar age from Frontiers in immunology
#508
of 689 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,537 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,055 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 689 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.